Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Pharmaceutical firm reports loss of $0.05 per share, clinical trial update
June 6th, 2005
A.P. Pharma, Inc., (APPA) reported financial results for the 3 months ended March 31, 2005, and provided an update on the clinical trial of its anti-nausea drug. A.P. Pharma reported an 11% increase in royalties for the first quarter of 2005 to $1,282,000, compared with $1,154,000 for the first quarter of 2004. First quarter royalties on sales of Carac and Retin-A Micro grew by 18% and 7%, respectively. Contract revenues totaled $78,000, compared with $26,000 for the first quarter of 2004. Total revenues for the first quarter of 2005 increased $180,000 or 15% to $1,360,000, compared with $1,180,000 for the first quarter of 2004. ...
Source: Biotech Business Week (2005-06-06)
|
